Agios Pharmaceuticals (United States)
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2023. Read More.
Open Access Percentage
63%
Total
Publications
550
Total Open
Publications
345
Total
Citations
42K
Open Access
Percentage
63%
Total
Publications
550
Total Open
Publications
345
Total
Citations
42K
Breakdown
Publisher Open
25%
Both
29%
Other Platform Open
9%
Closed
37%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 28%
83
Hybrid 21%
63
No Guarantees 51%
151
Other Platform Open
Domain 91%
190
Institution 14%
30
Other Internet 10%
21
Preprint 7%
15
Public 5%
11
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 190 |
Europe PMC | Domain | 82 |
Figshare | Public | 17 |
bioRxiv | Preprint | 13 |
DOI | Other Internet | 7 |
California Digital Library - eScholarship | Other Internet | 7 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 4 |
University of Michigan - Deep Blue | Institution | 4 |
University of California - eScholarship University of California | Institution | 3 |
King's College London - Research Portal | Institution | 3 |